Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUTAMICS II: Glutamate in Coronary Surgery
NCT02592824Phase 3Completed
- Start
- Nov 2015
- Primary completion
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Glutamic acid in heart failure (HF). Started Nov 2015; status: completed.
02
Drugs
Glutamic acid
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02592824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592824.